Plainsboro, NJ, United States of America

Charles Pak


Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 216(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (2000 - 2001)
  • Princeton, NJ (US) (2002)

Company Filing History:


Years Active: 2000-2002

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Charles Pak

Introduction

Charles Pak is a notable inventor based in Plainsboro, NJ (US), recognized for his significant contributions to the field of drug delivery systems. With a total of five patents to his name, Pak has focused on developing advanced methods for delivering therapeutic agents effectively to target cells.

Latest Patents

Among his latest patents are the innovations related to peptide-lipid conjugates and liposomal drug delivery. The peptide-lipid conjugates are designed to be incorporated into liposomes, allowing for selective destabilization of the liposomes near target peptidase-secreting cells. This targeted approach enables the delivery of liposomes directly to the vicinity of these cells, which is crucial for treating various diseases, disorders, or conditions such as tumors, microbial infections, and inflammations. Another significant patent involves N-acyl phosphatidylethanolamine-mediated liposomal drug delivery. This invention provides liposomes that contain one or more N-acylated phosphatidylethanolamines, which are instrumental in localizing the delivery of bioactive agents to specific cells.

Career Highlights

Throughout his career, Charles Pak has worked with prominent companies in the pharmaceutical industry, including The Liposome Company, Inc. and Elan Pharmaceutical Technologies, Inc. His work has been pivotal in advancing the understanding and application of liposomal drug delivery systems.

Collaborations

Pak has collaborated with esteemed colleagues such as Paul R. Meers and Shaukat Ali, contributing to the development of innovative solutions in drug delivery.

Conclusion

Charles Pak's inventive work in liposomal drug delivery systems showcases his commitment to improving therapeutic outcomes for patients. His patents reflect a deep understanding of biochemistry and a dedication to addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…